middl
east
respiratori
syndrom
coronaviru
merscov
infect
associ
signific
mortal
rate
exist
drug
show
poor
efficaci
identifi
novel
targetspathway
requir
mer
infect
therefor
import
develop
novel
therapeut
envelop
viru
transloc
endolysosom
system
provid
one
pathway
cellular
entri
merscov
context
ca
permeabl
channel
within
endolysosom
system
regul
lumin
environ
traffick
event
merit
investig
role
regul
process
traffick
merscov
knockdown
endogen
twopor
channel
tpc
target
ca
mobil
second
messeng
naadp
impair
infect
merscov
spike
pseudoviru
particl
transloc
assay
effect
select
knockdown
lysosom
cation
channel
without
effect
pharmacolog
inhibit
naadpevok
ca
releas
use
sever
bisbenzylisoquinolin
alkaloid
also
block
mer
pseudoviru
transloc
knockdown
bias
endosom
bias
lysosom
decreas
activ
furin
proteas
facilit
mer
fusion
cellular
membran
pharmacolog
genet
inhibit
activ
also
inhibit
endosom
motil
impair
pseudoviru
progress
endolysosom
system
overal
data
support
select
spatial
autonom
role
tpc
within
acid
organel
support
merscov
transloc
coronavirus
cov
envelop
singl
strand
rna
virus
caus
respiratori
enter
infect
across
broad
rang
anim
speci
sever
coronavirus
recent
emerg
zoonot
infect
caus
lifethreaten
human
diseas
exemplifi
sever
acut
respiratori
syndrom
sarscov
epidem
well
recent
cluster
infect
caus
middl
east
respiratori
syndrom
coronaviru
merscov
merscov
lineag
c
betacoronaviru
first
isol
summer
hospit
patient
saudi
arabia
date
mer
case
worldwid
merscov
infect
caus
symptom
high
fever
acut
progress
pneumonia
human
infect
associ
signific
mortal
rate
individu
comorbid
vaccin
exist
trial
drug
immun
respons
modul
demonstr
poor
efficaci
vivo
consider
interest
identifi
optim
novel
therapi
resolv
merscov
infect
therapeut
strategi
encompass
target
viral
compon
well
hostbas
process
support
merscov
infect
replic
consequ
resolut
cell
biolog
merscov
infect
illumin
cellular
infrastructur
control
viral
entri
organel
passag
transfer
cytoplasm
replic
particular
interest
evalu
new
host
target
promis
develop
repurpos
merscov
therapeut
research
cell
biolog
mer
shown
merscov
particl
entri
facilit
interact
viral
spike
protein
specif
host
surfac
receptor
dipeptidyl
peptidas
also
known
proteolyt
prime
spike
protein
promot
fusion
viral
envelop
host
cell
membran
thu
allow
success
transloc
infecti
viral
genom
host
cell
recent
report
demonstr
proteolyt
prime
membran
fusion
may
occur
either
cell
surfac
via
serin
proteas
intracellularli
endocyt
compart
via
proprotein
convertas
furin
follow
clathrinmedi
endocytosi
viru
traffic
endolysosom
system
proteolyt
activ
host
proteas
mediat
vesicular
fusion
liber
cytoplasm
subcellular
transloc
pathway
afford
opportun
pharmacolog
intervent
gener
manipul
endolysosom
function
inhibit
endocytosi
cytoskelet
dynam
bulk
alkal
acid
organel
shown
impair
merscov
infect
observ
provid
justif
pharmacolog
profil
target
within
acid
organel
identifi
novel
select
opportun
impair
merscov
transloc
endolysosom
system
ion
channel
twopor
channel
mucolipin
famili
eg
resid
within
endolysosom
system
regul
endolysosom
microenviron
traffick
function
merscov
transloc
releas
cytoplasm
requir
interplay
endolysosom
milieu
abil
ca
permeabl
channel
acut
regul
lumin
ionic
composit
ph
promot
consider
potenti
therapeut
target
manipul
endolysosom
ion
channel
function
shown
impact
endolysosom
morpholog
homeostat
traffick
varieti
cell
type
pharmacolog
manipul
channel
may
therefor
permit
defter
approach
impair
merscov
transloc
gener
perturb
endolysosom
function
special
relev
recent
discoveri
natur
product
tetrandrin
act
potent
blocker
tpc
activ
ebola
infect
reduc
viral
titer
serum
infect
mice
efficaci
tetrandrin
relat
interfer
late
step
ebola
viru
transloc
possibl
prevent
viralendosom
membran
fusion
within
structur
interf
late
endosomelysosom
matur
process
data
provid
impetu
consid
tpc
druggabl
target
combat
potenti
broad
rang
infecti
pathogen
must
travers
resid
within
acid
ca
store
milieu
use
pharmacolog
molecular
approach
address
concept
context
merscov
infect
contribut
play
endolysosom
channel
facilit
merscov
transloc
current
unknown
chemic
sourc
follow
hernandezin
metocurin
thaligin
isofangchinolin
cycleanin
spec
chemistri
databas
invivogen
glyphebnaphthylamid
gpn
santa
cruz
biotechnolog
echelon
bioscienc
dnmapdd
cayman
chemic
fumonisin
enzo
life
scienc
n
n
bi
n
acetyloxi
methoxi
bi
acetyloxi
methyl
ester
baptaam
biotium
ligand
purchas
sigma
aldrich
naadp
synthes
nicotinamid
adenin
dinucleotid
phosphat
previous
describ
clontech
antigfp
rabbit
polyclon
antirhodopsin
mous
monoclon
antiha
rabbit
polyclon
antigapdh
rabbit
polyclon
antibodi
santa
cruz
plasmid
encod
p
gfp
sandip
patel
ucl
describ
previous
dougla
kim
addgen
plasmid
tom
gallah
loyola
l
qing
zhong
addgen
plasmid
respect
silenc
select
sirna
target
nontarget
neg
control
sirna
purchas
invitrogen
sirna
sequenc
sirna
gcgucuucuu
caucgugua
sirna
ggcuacuauuaucucaaua
sirna
cgguauuacucgaacguau
sirna
acagaa
gugugguuaaaga
sirna
ccuucgccgucgucucaaa
sirna
gaucacguuugacaacaaa
sirna
ucacagcacuugugaggaatt
sirna
cuaccuacaucgg
ccuuaatt
sirna
ccuugauagauguuaccaatt
sirna
gcaguuccaugguacaccatt
sirna
ggcta
ttacttcttcaatttt
sirna
gcattgcctctgatgtcaatt
human
embryon
kidney
sourc
atcc
human
liver
cell
human
bone
osteosarcoma
gift
charl
rice
rockefel
eugen
brailoiu
templ
respect
cell
line
maintain
dmem
invitrogen
supplement
fetal
bovin
serum
fb
invitrogen
unitsml
penicillin
streptomycin
lglutamin
invitrogen
cultur
co
transfect
plasmid
dna
perform
dish
nunc
use
lipofectamin
invitrogen
cell
transfect
use
ng
dna
construct
use
dna
lipofectamin
ratio
complex
prepar
optimem
invitrogen
ad
cell
dmem
without
fb
antibiot
complex
remov
h
media
exchang
dmem
contain
fb
transfect
sirna
perform
dish
use
interferin
polyplu
accord
vendor
protocol
cell
passag
three
time
maintain
subconflu
cours
day
time
sirna
interferin
complex
replenish
ensur
protein
knockdown
knockdown
valid
rtpcr
posit
neg
control
mer
pseudoviru
manipul
carri
describ
previous
merscovspikepseudotyp
retrovirus
express
luciferas
report
gene
prepar
cotransfect
cell
plasmid
carri
envdefect
luciferaseexpress
genom
plasmid
encod
merscov
spike
protein
protein
previous
shown
necessari
suffici
facilit
merscov
cell
entri
merspseudoviru
particl
harvest
supernat
h
transfect
cell
express
endogen
use
resolv
effect
drug
merspseudoviru
transloc
cell
seed
plate
midwest
scientif
concentr
cellswel
follow
day
cell
preincub
individu
drug
final
concentr
h
prior
merspseudoviru
addit
cell
incub
co
addit
h
presenc
drug
pseudoviru
h
cultur
media
replac
complet
dmem
cell
incub
h
cell
wash
time
dpb
invitrogen
assay
luciferas
activ
cell
lyse
lysi
buffer
promega
per
well
lysat
transfer
solidwhit
plate
corn
mix
luciferas
substrat
promega
luminesc
rel
luminesc
unit
rlu
measur
use
glomaxmulti
detect
system
promega
luminesc
valu
report
rel
level
measur
cell
treat
viru
alon
background
correct
luminesc
valu
cell
unexpos
viru
except
indic
cell
viabil
assay
cell
lyse
h
post
drug
treatment
use
cell
lysi
buffer
promega
lysat
transfer
solid
white
plate
screen
atpbas
viabil
assay
celltiterglo
promega
accord
vendor
protocol
final
molecular
manipul
cell
cell
well
use
owe
higher
transfect
extra
sampl
harvest
immunoblot
rna
extract
sampl
use
studi
pseudoviru
infect
coloc
analys
cell
cell
cotransfec
transfect
plasmid
encod
gfptag
protein
interest
one
day
transfect
cell
incub
merspseudoviru
h
allow
adsorpt
pseudoviru
particl
receptor
cell
surfac
brief
incub
min
co
cell
fix
methanol
sampl
block
bsa
incub
primari
antibodi
dilut
overnight
cell
incub
alexa
fluorconjug
secondari
antibodi
invitrogen
h
room
temperatur
cell
imag
olympu
invert
microscop
use
planapochromat
oilimmers
object
use
spin
disk
confoc
unit
yogogawa
imag
captur
use
clara
interlin
ccd
camera
andor
cell
transfect
plasmid
encod
two
day
prior
microinject
experi
one
day
posttransfect
cell
seed
onto
collagen
coat
mattek
dish
microinject
experi
dish
mount
olympu
invert
microscop
equip
piezo
nanoposit
stage
prior
scientif
cell
perfus
ca
free
hank
balanc
salt
solut
thermo
scientif
rate
mlmin
isol
cell
express
identifi
fluoresc
select
inject
cell
morpholog
assess
acquir
zstack
imag
reconstruct
threedimension
model
cell
inject
region
rel
close
nucleu
cell
peripheri
target
inject
site
femptotip
eppendorf
inject
pipett
backfil
intracellular
buffer
mm
kcl
mm
nacl
mm
hepe
ph
contain
either
vehicl
naadp
nm
posit
use
eppendorf
micromanipul
system
cell
inject
zposit
approxim
cell
thick
site
inject
use
eppendorf
inject
paramet
hpa
inject
pressur
hpa
compens
pressur
inject
durat
angl
inject
speed
cell
inject
imag
ex
nm
em
nm
bandpass
use
planapochromat
object
fluoresc
chang
monitor
use
yokogawa
spin
disk
confoc
andor
ixon
ultra
emccd
camera
imag
acquisit
data
collect
done
use
metamorph
version
cell
lyse
nutat
mixer
icecold
lysi
buffer
consist
pb
invitrogen
triton
fluka
complet
proteas
inhibitor
roch
protein
concentr
determin
bradford
assay
pierc
protein
load
onto
anykd
miniprotean
tgx
gel
biorad
sdspage
electrophoresi
protein
transfer
nitrocellulos
membran
use
transblot
turbo
biorad
semidri
transfer
machin
membran
block
h
room
temperatur
milk
pb
supplement
prior
addit
primari
antibodi
dilut
antigfp
antiha
antibodi
dilut
antigapdh
antibodi
overnight
incub
follow
day
membran
incub
irdy
secondari
antibodi
dilut
licor
h
room
temperatur
signal
detect
use
licor
odyssey
imag
system
rna
isol
cell
sirna
treatment
use
trizol
invitrogen
accord
vendor
protocol
rna
aliquot
frozen
prior
rtpcr
analysi
rtpcr
evalu
knockdown
mrna
interest
assess
use
follow
primer
step
rtpcr
system
platinum
taq
invitrogen
use
convert
mrna
cdna
amplifi
sampl
singl
reaction
semi
quantit
rtpcr
reaction
cycl
multiplex
amplifi
gapdh
mrna
interest
simultan
pcr
product
separ
agaros
gel
gel
imag
use
myecl
thermo
fisher
quantifi
densitometri
imagej
intracellular
furin
activ
detect
use
fluorogen
substrat
bocrvrramc
enzo
life
scienc
pharmacolog
assay
cell
cultur
presenc
vehicl
drug
h
left
untreat
knockdown
assay
cell
treat
indic
sirna
describ
cell
wash
pb
lyse
cold
pb
contain
triton
phosphatas
inhibitor
thermo
scientif
protein
concentr
determin
bradford
assay
dilut
dispens
individu
well
clearbottom
black
wall
plate
cellstar
furin
substrat
final
concentr
ad
well
test
direct
inhibit
furin
activ
fangchinolin
ad
immedi
addit
furin
substrat
fluoresc
monitor
use
tecan
plate
reader
ex
nm
em
nm
baselin
endosom
motil
measur
cell
cultur
presenc
fitcdextran
sigma
complet
media
min
allow
endocyt
uptak
rins
pb
imag
motil
endosom
express
wildtyp
dominantneg
done
transfect
cell
indic
gfptag
construct
imag
gfp
fluoresc
assess
pharmacolog
inhibit
endosom
motil
perform
treat
cell
indic
compound
h
prior
load
fitcdextran
describ
cell
imag
olympu
microscop
equip
piezo
nanoposit
stage
prior
scientif
use
planapochromat
oilimmers
object
use
spin
disk
confoc
unit
yokogawa
ixon
emccd
camera
andor
endosom
structur
track
acquir
seri
zstack
time
cours
min
maximum
intens
project
zstack
time
point
gener
track
particl
addon
use
metamorph
assess
movement
endosom
produc
trajectori
plot
mer
pseudoviru
entri
subcellular
traffick
monitor
use
luciferas
assay
pseudoviru
genom
engin
encod
luciferas
gener
luminesc
signal
releas
cytoplasm
therebi
report
effici
subcellular
transloc
event
receptor
bind
intern
endolysosom
traffick
cytoplasm
releas
fig
valid
assay
hand
preliminari
experi
perform
follow
infect
cell
use
drug
previous
shown
inhibit
specif
step
requir
mer
infect
ouabain
cardiac
glycosid
inhibitor
earli
coronaviru
intern
event
inhibit
merscov
pseudoviru
transloc
appli
prior
pseudoviru
addit
fig
similarli
chlorpromazin
inhibitor
clathrinmedi
endocytosi
result
lower
luminesc
valu
inhibit
also
observ
sever
drug
elev
endolysosom
ph
includ
chloroquin
lysomotrop
weak
base
nh
cl
bafilomycin
inhibitor
vacuolartyp
h
atpas
cell
permeabl
ca
chelat
baptaam
also
inhibit
merscov
pseudoviru
transloc
fig
bafilomycin
particularli
effect
inhibitor
merscov
pseudoviru
traffick
reduc
luminesc
signal
background
level
fig
inhibitori
effect
ablat
bafilomycin
applic
delay
h
viral
addit
fig
inhibitori
action
baptaam
similarli
timesensit
supplementari
fig
result
demonstr
merscov
pseudoviru
transloc
rapid
regul
contemporan
endolysosom
microenviron
endolysosom
ion
channel
includ
twopor
channel
famili
mucolipin
famili
trpml
trp
channel
fig
regul
organellar
microenviron
traffick
dynam
examin
impact
merscov
pseudoviru
transloc
appli
molecular
pharmacolog
tool
modul
individu
channel
activ
rnai
analys
construct
express
cell
capit
upon
high
transfect
cell
line
experi
assay
mer
infect
cell
also
necessit
coexpress
merscov
entri
receptor
dipeptidyl
peptidas
owe
low
endogen
express
luminesc
level
low
presenc
pseudoviru
endogen
alon
express
result
enhanc
luminesc
signal
fig
coexpress
gfp
control
plasmid
alter
infect
level
fig
neg
posit
control
transfect
domin
neg
rab
construct
n
impair
endocyt
activ
depress
merscov
pseudoviru
infect
wherea
constitut
activ
rab
variant
l
potenti
merscov
pseudoviru
infect
fig
loss
function
analys
perform
use
multipl
sirna
target
individu
endolysosom
ca
channel
discret
sirna
target
transfect
cell
infect
assay
perform
day
final
transfect
wherea
two
discret
control
sirna
dual
sirna
target
littl
effect
assay
knockdown
endogen
markedli
inhibit
mer
transloc
fig
cotransfect
sirna
enhanc
inhibitori
effect
fig
penetr
knockdown
attain
sirna
evalu
rtpcr
set
transfect
use
pseudoviru
infect
assay
repres
gel
shown
fig
togeth
associ
densitometri
addit
experi
evidenc
knockdown
individu
channel
fig
overexpress
tpc
isoform
manipul
known
perturb
endolysosom
traffick
also
impair
merscov
pseudoviru
transloc
fig
overexpress
without
effect
fig
inhibitori
effect
depend
appropri
subcellular
target
activ
channel
overexpress
function
channel
rerout
acid
ca
store
cell
surfac
delet
nh
termin
lysosom
target
motif
inhibit
merscov
pseudoviru
infect
fig
moreov
inhibitori
action
manipul
caus
alter
express
similar
express
level
observ
across
condit
supplementari
fig
fig
merspseudoviru
assay
valid
top
schemat
represent
merspseudoviru
infect
pathway
highlight
individu
process
mer
transloc
bind
intern
traffick
releas
target
pharmacotherapi
mer
particl
associ
host
entri
receptor
follow
intern
traffick
acid
ca
store
releas
luciferaseencod
rna
cytoplasm
infect
cell
fusion
intern
membran
note
pseudoviru
transloc
assay
use
experi
replic
defect
report
viru
transloc
bottom
traffick
event
endolysosom
system
regul
activ
ion
channel
resid
within
acid
ca
store
includ
member
trpml
activ
pi
p
tpc
famili
activ
naadp
pi
p
b
effect
drug
incub
span
h
prior
pseudoviru
addit
h
coincub
mer
infect
measur
term
luminesc
intens
measur
day
postinfect
drug
concentr
ouabain
nm
chlorpromazin
chloroquin
nh
cl
mm
baptaam
bafilomycin
nm
pseudoviru
infect
unaffect
presenc
dmso
drug
vehicl
c
delay
exposur
bafilomycin
h
exposur
h
pseudoviru
addit
attenu
inhibitori
effect
bafilomycin
nm
mer
infect
data
experi
normal
untreat
control
sampl
valu
repres
mean
sem
three
independ
experi
pvalu
p
p
calcul
rel
dmso
sampl
coloc
tpc
isoform
merscov
spike
protein
examin
immunofluoresc
stain
tag
spike
protein
experi
perform
use
cell
owe
fact
cell
line
express
higher
endogen
level
compar
cell
obviat
need
transfect
allow
examin
merscov
pseudoviru
traffick
nativ
cell
line
signal
evid
cell
unexpos
pseudoviru
merscov
spike
protein
could
resolv
vesicular
structur
cell
previous
incub
pseudoviru
h
fix
min
incub
fig
cotransfect
evidenc
mer
cov
spike
protein
coloc
within
subset
posit
vesicl
supplementari
fig
express
tpc
construct
evidenc
coloc
mer
cov
spike
protein
bias
toward
lysosom
bias
toward
endosom
sampl
examin
fig
coloc
merscov
spike
protein
also
observ
fig
collect
data
consist
mer
pseudoviru
transloc
tpc
posit
endolysosom
organel
fig
properti
andor
dynam
structur
permiss
merscov
pseudoviru
transloc
regul
endogen
tpc
activ
fig
tpc
modul
attenu
mer
traffick
endolysosom
system
tpc
activ
regul
endolysosom
phospholipid
pi
p
well
potent
ca
releas
second
messeng
naadp
fig
lipid
modul
naadp
antagonist
rang
voltageoper
ion
channel
blocker
shown
regul
tpc
activ
examin
effect
tpc
regul
merscov
pseudoviru
transloc
fix
concentr
primari
drug
screen
perform
cell
goal
identifi
plasma
membraneperm
compound
inhibitori
activ
merscov
pseudoviru
transloc
effect
naadp
antagonistspor
blocker
fig
lipid
modul
supplementari
fig
describ
turn
tpc
show
affin
broad
rang
voltageoper
channel
ligand
possibl
reflect
ancient
evolutionari
pedigre
anteced
four
domain
voltageg
ion
channel
consist
observ
sever
na
channel
blocker
procain
benzocain
voltageoper
ca
antagonist
verapamil
nicardipin
nimodipin
attenu
merscov
pseudoviru
transloc
fig
particular
relev
effect
bisbenzylisoquinolin
alkaloid
compound
consist
dual
benzylisoquinolin
moieti
link
togeth
ether
bridg
fig
supplementari
fig
merscov
spike
protein
coloc
endolysosom
ion
channel
posit
structur
cell
transfect
top
green
middl
green
bottom
green
subsequ
infect
merspseudoviru
red
cell
fix
immunostain
merscov
spike
protein
visual
confoc
microscopi
white
box
overlay
panel
right
show
enlarg
region
assess
coloc
red
green
channel
scalebar
left
column
inset
right
fig
compound
interest
light
recent
discoveri
tetrandrin
bisbenzylisoquinolin
alkaloid
natur
product
block
tpc
activ
potent
inhibit
ebola
viru
infect
vitro
vivo
therefor
screen
sever
bisbenzylisoquinolin
alkaloid
two
differ
group
fig
tubocurarinelik
ligand
isoquinolin
pair
nonadjac
within
bisbenzylisoquinolin
ring
structur
abab
headtotail
tetrandrinelik
ligand
isoquinolin
group
directli
conjoin
aabb
headtohead
tailtotail
two
group
discrimin
shade
intens
fig
b
structur
individu
compound
provid
supplementari
data
supplementari
fig
sever
structureact
insight
clear
screen
dataset
first
tubocurarinelik
bisbenzylisoquinolin
tubocurarin
cycleanin
metocurin
consider
less
effect
compar
tetrandrinelik
ligand
tetrandrin
thaligin
fangchinolin
strongli
impair
merscov
pseudoviru
transloc
fig
b
second
presenc
individu
methoxi
moieti
around
compound
ring
structur
markedli
influenc
penetr
individu
ligand
exampl
ring
substitut
preserv
fangchinolin
thaligin
decreas
berbamin
herandezin
drug
effect
rel
antiebola
prototyp
tetrandrin
final
fangchinolin
stereoisom
thaligin
isofangchinolin
effect
compound
inhibit
mer
transloc
assay
compound
initi
screen
evalu
full
concentrationrespons
relationship
inhibit
merscov
pseudoviru
infect
fig
rel
sensit
screen
compound
fangchinolin
ic
tetrandrin
ic
berbamin
ic
consist
primari
screen
fix
concentr
cellular
viabil
measur
parallel
use
calcul
select
index
select
compound
calcul
select
index
cytotox
concentr
cc
cellular
toxic
ic
mer
inhibit
underscor
improv
perform
fangchinolin
tetrandrin
fig
inset
data
support
efficaci
specif
bisbenzylisoquinolin
alkaloid
agent
target
fig
pharmacolog
blockad
mer
pseudoviru
infect
singleconcentr
drug
screen
identifi
ion
channel
modul
inhibit
mer
pseudoviru
transloc
cell
treat
indic
drug
h
start
h
prior
incub
mer
pseudoviru
ie
h
coincub
drug
repres
known
modul
intracellular
trpml
tpc
channel
voltageoper
channel
blocker
well
seri
structur
relat
bisbenzylisoquinolin
encompass
known
tpc
blocker
tetrandrin
screen
bisbenzylisoquinolin
compris
two
group
tubocurarinelik
compound
light
dash
tetrandrinelik
compound
heavi
dash
pvalu
p
p
b
structur
repres
two
group
bisbenzylisoquinolin
highlight
confom
download
pubchem
display
pubchem
viewer
c
complet
concentr
respons
relationship
inhibit
mer
transloc
fangchinolin
tetrandrin
berbamin
inset
select
index
cc
cellular
toxic
ic
pseudoviru
transloc
indic
compound
inhibit
ca
signal
cell
microinject
naadp
nm
pipett
concentr
drug
treatment
dmso
tetrandrin
fangchinolin
min
preincub
trace
repres
averag
independ
inject
error
bar
repres
sem
assess
abil
compound
inhibit
naadpevok
ca
releas
confoc
ca
imag
experi
perform
human
cell
microinject
naadp
preincub
cell
tetrandrin
fangchinolin
inhibit
ca
signal
trigger
naadp
microinject
inhibit
tetrandrin
fangchinolin
respect
evidenc
fangchinolin
effect
inhibitor
naadpevok
ca
releas
fig
merscov
pseudoviru
transloc
fig
c
antivir
activ
observ
follow
inhibit
ip
cadprevok
ca
releas
fig
inhibit
naadpevok
ca
releas
merscov
pseudoviru
transloc
compound
due
lysosomotrop
found
signific
decreas
lysosom
ca
content
disrupt
lysosom
ph
upon
addit
drug
supplement
fig
final
effect
two
cell
permeabl
endolysosom
ion
channel
modul
examin
naadp
antagonist
trpml
agonist
show
poor
inhibitori
activ
mer
transloc
assay
fig
surpris
wide
employ
naadp
blocker
howev
hand
also
fail
potent
inhibit
naadpevok
ca
releas
either
mammalian
cell
fig
sea
urchin
homogen
fig
suggest
caution
interpret
result
obtain
commerci
sourc
activ
cell
permeabl
trpml
agonist
modul
merscov
pseudoviru
infect
fig
confirm
applic
mammalian
cell
line
elicit
clear
ca
transient
data
shown
tpc
channel
also
regul
bioactiv
lipid
includ
pi
p
sphingosin
addit
pikfyv
inhibitor
reduc
pi
p
level
phosphoinositid
activ
tpc
channel
decreas
merscov
pseudoviru
transloc
supplementari
fig
b
sphingosin
gener
action
acid
ceramidas
ac
ceramid
product
acid
sphingomyelinas
asm
activ
supplementari
fig
acid
sphingomyelinas
requir
ebola
infect
although
role
asm
ac
studi
merscov
pseudoviru
infect
cell
expos
pseudoviru
addit
antidepress
drug
desipramin
amitriptylin
act
function
inhibitor
asm
inhibit
merscov
pseudoviru
transloc
supplementari
fig
concentrationrespons
curv
demonstr
potent
inhibit
ic
nm
desipramin
ic
amitriptylin
littl
deleteri
effect
cellular
viabil
concentr
rang
studi
supplementari
fig
pharmacolog
inhibit
ac
reduc
sphingosin
level
also
reduc
luminesc
level
supplementari
fig
contrast
incub
fumonisin
inhibitor
ceramid
synthas
enzym
local
endoplasm
reticulum
util
sphingosin
synthes
ceramid
significantli
decreas
luminesc
valu
discret
sirna
target
inhibit
mer
transloc
supplementari
fig
success
knockdown
enzym
valid
supplementari
fig
therefor
inhibit
enzym
upstream
downstream
activ
sphingosin
impair
merscov
pseudoviru
infect
summari
data
demonstr
dysregul
known
lipid
tpc
regul
also
imped
mer
pseudoviru
transloc
tpc
activ
chang
cytosol
lumin
microenviron
within
acid
ca
store
local
cytoplasm
ion
flux
potenti
regul
vesicular
dynam
fusion
event
impact
merscov
pseudoviru
progress
endolysosom
system
tpc
trigger
chang
lumin
ca
ph
may
also
regul
merscov
pseudoviru
transloc
regul
proprotein
convertas
activ
need
proteolyt
activ
spike
protein
therebi
merscov
fusion
releas
cytoplasm
therefor
examin
effect
fangchinolin
cell
biolog
aspect
merscov
pseudoviru
transloc
first
assess
effect
drug
incub
merscov
pseudoviru
progress
tpcposit
structur
treatment
cell
fangchinolin
increas
mer
particl
coloc
label
structur
fig
quantif
coloc
use
pearson
correl
coeffici
singl
cell
region
interest
fix
sampl
show
fangchinolin
treatment
increas
level
pixeltopixel
covari
across
mer
tpcposit
structur
fig
inset
analysi
merscov
spike
protein
coloc
tpc
use
differ
algorithm
mander
coeffici
also
demonstr
similar
increas
coloc
fangchinolin
treatment
fig
result
suggest
drugevok
blockad
endolysosom
merscov
pseudoviru
transloc
event
live
cell
imag
experi
also
evid
fangchinolin
treatment
impact
mobil
fluoresc
dextran
label
endosom
structur
singl
particl
track
analysi
reveal
incub
cell
fangchinolin
tetrandrin
decreas
mobil
dextranlabel
endosom
structur
fig
impair
movement
structur
also
seen
cell
overexpress
poredead
mutant
p
gfp
suggest
drugevok
inhibit
activ
underpin
effect
endosom
motil
fig
next
assess
effect
drug
incub
tpc
knockdown
activ
furin
ca
depend
serin
endoproteas
experi
kinet
furinevok
cleavag
fluorogen
substrat
bocrvrramc
measur
cell
lysat
differ
experiment
condit
cell
pretreat
cell
fangchinolin
h
markedli
reduc
rate
substrat
cleavag
control
fig
b
contrast
inhibit
observ
acut
drug
treatment
demonstr
fangchinolin
act
direct
furin
inhibitor
fig
b
similar
assay
repeat
cell
treat
valid
sirna
fig
knockdown
either
tpc
isoform
impair
furin
activ
decreas
initi
rate
substrat
cleavag
fig
data
show
pharmacolog
molecular
inhibit
tpc
function
impair
furin
activ
consequ
test
whether
furin
overexpress
could
rescu
drug
inhibit
merscov
pseudoviru
transloc
overexpress
furin
markedli
attenu
drugevok
inhibit
merscov
pseudoviru
infect
cell
fig
inhibit
observ
tetrandrin
fangchinolin
control
experi
inhibit
consider
attenu
transfect
exogen
furin
inhibit
fig
overexpress
serin
proteas
bia
merscov
pseudoviru
transloc
direct
entri
via
plasma
membran
also
render
bisbenzylisoquinolin
alkaloid
ineffect
block
merscov
pseudoviru
infect
fig
lack
inhibitori
action
tetrandrin
fangchinolin
direct
cell
entri
plasma
membran
rule
possibl
compound
act
process
downstream
membran
fusion
includ
transcript
translat
data
confirm
tetrandrin
fangchinolin
act
block
traffick
process
intern
merscov
pseudoviru
particl
within
endolysosom
system
merscov
infect
clinic
challeng
associ
high
mortal
rate
due
diseas
sever
lack
effect
pharmacotherapi
demonstr
endolysosom
tpc
may
repres
druggabl
host
target
merscov
antivir
therapi
base
data
show
inhibit
endogen
tpc
activ
via
either
molecular
pharmacolog
method
impair
gs
gunaratn
et
al
cell
calcium
cellular
transloc
merscov
pseudoviru
find
merit
consider
role
tpc
hostfactor
support
merscov
infect
potenti
druggabl
ion
channel
sourc
novel
antivir
issu
discuss
tpc
evolutionarili
ancient
ion
channel
resid
within
endolysosom
system
fulfil
homeostat
traffick
function
support
intern
substrat
distribut
mechanist
basi
channel
regul
endolysosom
traffick
event
subject
vari
specul
seem
clear
perturb
tpc
local
activ
away
physiolog
setpoint
disrupt
endolysosom
morpholog
substrat
traffick
import
subcellular
transport
extend
beyond
endogen
substrat
impact
highlight
context
ebola
infect
role
tpc
support
viral
transloc
evidenc
context
mer
anoth
singl
strand
rna
viru
investig
role
tpc
viral
infect
paradigm
infecti
diseas
pathogen
exploit
resid
within
endolysosom
deriv
organel
merit
tpc
support
mer
passag
cell
surfac
cytoplasm
fig
show
tpc
activ
necessari
support
traffick
event
passag
pseudoviru
particl
tpcposit
compart
endolysosom
traffick
pathway
effect
particl
progress
process
like
interdepend
tpc
also
regul
furin
activ
fig
tpc
activ
known
alter
endolysosom
ca
content
ph
factor
regul
activ
proprotein
convertas
furin
requir
proteolyt
activ
spike
protein
merscov
fusion
activ
cytoplasm
transloc
dysregul
lumin
microenviron
ph
ca
owe
chang
tpc
activ
may
impair
merscov
fusion
depend
proteas
level
divers
proteas
express
within
given
cell
type
inhibitori
nonaddit
effect
bias
toward
endosom
bias
toward
lysosom
knockdown
fig
suggest
mer
transloc
occur
throughout
proxim
distal
compart
within
acid
ca
store
prior
investig
mer
infect
suggest
fusion
cytoplasm
transloc
occur
earli
endosom
recent
studi
demonstr
inhibit
cathepsin
l
lysosom
cystein
proteas
block
mer
infect
studi
consist
demonstr
role
fig
conclus
drawn
current
data
role
tpc
appear
select
manipul
function
anoth
acid
ca
store
ion
channel
fail
impair
merscov
pseudoviru
infect
data
suggest
subspeci
endolysosom
channel
function
andor
traffick
pathway
tpc
inhibit
may
select
impair
subset
transport
substrat
rather
effect
global
disrupt
endolysosom
functiona
featur
may
prove
critic
advanc
viabil
tpc
select
drug
target
select
drug
action
tpc
also
evid
correl
extent
inhibit
naadpevok
ca
signal
impair
mer
transloc
fig
relationship
evidenc
companion
paper
drug
inhibit
mer
pseudoviru
transloc
inhibit
intracellular
ca
mobil
pathway
fig
even
though
role
tpc
amplifi
ca
signal
intracellular
ca
channel
beyond
endolysosom
system
well
appreci
short
data
support
select
spatial
autonom
role
tpc
within
acid
organel
support
mer
infect
tpc
druggabl
target
antivir
develop
topic
issu
given
renew
interest
repurpos
ca
channel
ligand
impair
viral
infect
although
attent
date
direct
toward
cell
surfac
target
voltageoper
ca
channel
vocc
howev
mani
vocc
blocker
also
inhibit
naadpevok
ca
releas
activ
high
micromolar
rang
like
due
pedigre
tpc
structur
blueprint
anteced
cell
surfac
voltageg
channel
architectur
tpc
blockad
may
therefor
constitut
compon
previous
describ
antivir
vocc
antagonist
action
promiscu
pharmacolog
tpc
may
nevertheless
prove
challeng
discov
select
high
affin
tpc
ligand
howev
emerg
capac
interrog
cell
biolog
assay
depend
tpc
function
explor
ii
miniatur
naadpevok
ca
releas
screen
platform
see
companion
paper
iii
integr
structurebas
approach
base
upon
recent
resolut
tpc
crystal
structur
collect
spur
opportun
identifi
novel
lead
optim
ligand
affin
select
channel
context
clear
structureact
correl
emerg
studi
bisbenzylisoquinolin
alkaloid
compound
wellstudi
natur
product
group
hundr
uniqu
compound
describ
display
activ
pathogen
eukaryot
bisbenzylisoquinolin
alkaloid
classifi
base
number
type
orient
ring
linkag
compound
studi
provid
limit
insight
structur
divers
seri
repres
compound
two
diphenyl
ether
linkag
differ
orient
headtotail
versu
headtohead
tailtotail
nevertheless
clear
insight
structureact
relationship
impact
mer
translocationintracellular
ca
releas
properti
discern
fig
provid
impetu
structur
explor
bisbenzylisoquinolin
scaffold
encompass
compound
differ
number
ring
linkag
effect
ring
flexibl
posit
natur
ring
substitut
well
stereochemistri
around
dual
asymmetr
carbon
note
potenc
tetrandrin
mer
lower
previous
report
tetrandrin
ebola
ten
nm
vitro
improv
perform
fangchinolin
tetrandrin
particular
assay
support
futur
optim
structur
activ
relationship
compound
seri
specif
pathogen
fig
also
noteworthi
experi
efficaci
good
select
indic
seen
fdaapprov
serotonin
reuptak
inhibitor
amitriptylin
desipramin
supplementari
fig
investig
interrelationship
antivir
activ
ssri
supplementari
fig
endolysosom
bioactiv
lipid
content
compound
act
function
inhibitor
acid
sphingomyelinas
effect
tpc
activ
also
warrant
conclus
find
support
uniqu
role
tpc
naadpsensit
ca
releas
mer
infect
provid
support
explor
develop
tpc
ligand
novel
antivir
therapeut
none
fig
pharmacolog
molecular
inhibit
tpc
reduc
furin
activ
cell
treat
vehicl
fangchinolin
lysat
harvest
cell
furin
activ
assess
use
fluorogen
substrat
bocrvrramc
drug
ad
either
h
prior
harvest
pretreat
immedi
addit
substrat
acut
repres
trace
shown
linear
rang
use
calcul
furin
substrat
cleavag
rfumin
shown
use
dash
line
b
quantif
cumul
data
set
furin
activ
pharmacolog
treat
lysat
pvalu
p
rel
dmso
control
c
cell
treat
indic
sirna
lysat
collect
assay
furin
activ
repres
trace
shown
linear
rang
substrat
cleavag
denot
use
dash
line
quantif
cumul
data
set
furin
activ
use
sirna
treat
cell
pvalu
p
rel
nontarget
sirna
treat
sampl
e
effect
furin
overexpress
pharmacolog
blockad
merspseudoviru
infect
pvalu
p
rel
empti
vector
transfect
dmso
treat
control
p
rel
empti
vector
transfect
sampl
treat
tetrandrin
fangchinolin
f
effect
tetrandrin
fangchinolin
treatment
cell
overexpress
